These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 7680859

  • 1. Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes.
    Ukena D, Schudt C, Sybrecht GW.
    Biochem Pharmacol; 1993 Feb 24; 45(4):847-51. PubMed ID: 7680859
    [Abstract] [Full Text] [Related]

  • 2. Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors.
    Choi OH, Shamim MT, Padgett WL, Daly JW.
    Life Sci; 1988 Feb 24; 43(5):387-98. PubMed ID: 2456442
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
    Hatzelmann A, Tenor H, Schudt C.
    Br J Pharmacol; 1995 Feb 24; 114(4):821-31. PubMed ID: 7539697
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M, Cover PO, Poyser RH, Buckingham JC.
    Br J Pharmacol; 1997 Jun 24; 121(3):459-68. PubMed ID: 9179387
    [Abstract] [Full Text] [Related]

  • 5. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN, Shiloh AO, Sauermelch CF, Sulpizio A, Michell MP, Cieslinski LB, Torphy TJ, Ohlstein EH.
    J Cereb Blood Flow Metab; 1997 Feb 24; 17(2):210-9. PubMed ID: 9040501
    [Abstract] [Full Text] [Related]

  • 6. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
    Shamim MT, Ukena D, Padgett WL, Daly JW.
    J Med Chem; 1989 Jun 24; 32(6):1231-7. PubMed ID: 2724296
    [Abstract] [Full Text] [Related]

  • 7. Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells.
    Pan X, Arauz E, Krzanowski JJ, Fitzpatrick DF, Polson JB.
    Biochem Pharmacol; 1994 Aug 17; 48(4):827-35. PubMed ID: 7521642
    [Abstract] [Full Text] [Related]

  • 8. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
    Daly JW, Padgett W, Shamim MT, Butts-Lamb P, Waters J.
    J Med Chem; 1985 Apr 17; 28(4):487-92. PubMed ID: 2984420
    [Abstract] [Full Text] [Related]

  • 9. Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus.
    Cortijo J, Bou J, Beleta J, Cardelús I, Llenas J, Morcillo E, Gristwood RW.
    Br J Pharmacol; 1993 Feb 17; 108(2):562-8. PubMed ID: 8383567
    [Abstract] [Full Text] [Related]

  • 10. Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.
    Martinson EA, Johnson RA, Wells JN.
    Mol Pharmacol; 1987 Mar 17; 31(3):247-52. PubMed ID: 3561384
    [Abstract] [Full Text] [Related]

  • 11. Respiratory effects of xanthines and adenosine analogs in rhesus monkeys.
    Howell LL, Morse WH, Spealman RD.
    J Pharmacol Exp Ther; 1990 Sep 17; 254(3):786-91. PubMed ID: 2395111
    [Abstract] [Full Text] [Related]

  • 12. Methylxanthine reversal of opioid-evoked inspiratory depression via phosphodiesterase-4 blockade.
    Ruangkittisakul A, Ballanyi K.
    Respir Physiol Neurobiol; 2010 Jul 31; 172(3):94-105. PubMed ID: 20444435
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.
    Souness JE, Villamil ME, Scott LC, Tomkinson A, Giembycz MA, Raeburn D.
    Br J Pharmacol; 1994 Apr 31; 111(4):1081-8. PubMed ID: 8032594
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction.
    Sebastião AM, Ribeiro JA.
    Br J Pharmacol; 1989 Jan 31; 96(1):211-9. PubMed ID: 2924073
    [Abstract] [Full Text] [Related]

  • 19. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
    Barnette MS, Manning CD, Price WJ, Barone FC.
    J Pharmacol Exp Ther; 1993 Feb 31; 264(2):801-12. PubMed ID: 7679736
    [Abstract] [Full Text] [Related]

  • 20. Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea-pig hearts.
    Bethke T, Meyer W, Schmitz W, Scholz H, Stein B, Thomas K, Wenzlaff H.
    Br J Pharmacol; 1992 Sep 31; 107(1):127-33. PubMed ID: 1384905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.